We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
BH3-mimetics: recent developments in cancer therapy.
- Authors
Townsend, Paul A.; Kozhevnikova, Maria V.; Cexus, Olivier N. F.; Zamyatnin Jr, Andrey A.; Soond, Surinder M.
- Abstract
The hopeful outcomes from 30 years of research in BH3-mimetics have indeed served a number of solid paradigms for targeting intermediates from the apoptosis pathway in a variety of diseased states. Not only have such rational approaches in drug design yielded several key therapeutics, such outputs have also offered insights into the integrated mechanistic aspects of basic and clinical research at the genetics level for the future. In no other area of medical research have the effects of such work been felt, than in cancer research, through targeting the BAX-Bcl-2 protein-protein interactions. With these promising outputs in mind, several mimetics, and their potential therapeutic applications, have also been developed for several other pathological conditions, such as cardiovascular disease and tissue fibrosis, thus highlighting the universal importance of the intrinsic arm of the apoptosis pathway and its input to general tissue homeostasis. Considering such recent developments, and in a field that has generated so much scientific interest, we take stock of how the broadening area of BH3-mimetics has developed and diversified, with a focus on their uses in single and combined cancer treatment regimens and recently explored therapeutic delivery methods that may aid the development of future therapeutics of this nature.
- Subjects
CARCINOGENESIS; MEDICAL research; CANCER treatment; DRUG design; CARDIOVASCULAR diseases
- Publication
Journal of Experimental & Clinical Cancer Research (17569966), 2021, Vol 40, Issue 1, p1
- ISSN
1756-9966
- Publication type
Article
- DOI
10.1186/s13046-021-02157-5